16.12.2012 Views

Therapies for Children With Autism Spectrum Disorders

Therapies for Children With Autism Spectrum Disorders

Therapies for Children With Autism Spectrum Disorders

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Evidence Table. <strong>Therapies</strong> <strong>for</strong> children with ASD (continued)<br />

Study<br />

Inclusion/ Exclusion Baseline<br />

Description Intervention<br />

Criteria/ Population Measures Outcomes<br />

Intervention 2 mg/day fixed dose to recruitment<br />

G1/G2: P <<br />

setting:<br />

(0.5 mg starting dose • Significant active<br />

0.0001<br />

Clinic<br />

with 0.5 mg increments medical problem<br />

Harms:<br />

Enrollment<br />

period:<br />

in weekly dose <strong>for</strong> first<br />

3 weeks)<br />

• <strong>Children</strong> without<br />

definitive diagnosis of<br />

Treatment-related<br />

AEs, n (%):<br />

NR<br />

Funding:<br />

NR<br />

Author industry<br />

• > 40 kg: titrated up to 3 autism as in severe/<br />

mg/day fixed dose profound mental<br />

Duration: 10 weeks retardation<br />

Assessments:<br />

Age, years ± SD (range):<br />

Constipation:<br />

G1: 4 (20)<br />

G2: 3 (15)<br />

G1/G2: P = NS<br />

relationship ABC-C, Extrapyramidal G1: 6.9 ± 1.86 (3-11)<br />

Nervousness:<br />

disclosures: Symptoms Rating Scale G2: 6.75 ± 1.8 (3-11)<br />

G1: 1 (5)<br />

NR<br />

administered by blinded Mental age:<br />

G2: 2 (10)<br />

Design: rater in clinic<br />

NR<br />

G1/G2: P = NS<br />

RCT, double blind, Groups:<br />

Gender, n (%):<br />

Daytime<br />

placebo controlled G1: piracetam +<br />

risperidone<br />

Male:<br />

G1: 16 (80)<br />

drowsiness:<br />

G1: 7 (35)<br />

G2: placebo + risperidone G2: 14 (70)<br />

G2: 9 (45)<br />

Co-interventions held Female:<br />

G1/G2: P = NS<br />

stable during treatment: G1: 4 (20)<br />

Morning<br />

NA<br />

G2: 6 (30)<br />

drowsiness:<br />

Frequency of contact Race/ethnicity:<br />

G1: 11 (55)<br />

during study:<br />

Ratings at weeks 0, 2, 4,<br />

NR<br />

SES:<br />

G2: 8 (40)<br />

G1/G2: P = NS<br />

6, 8, and 10<br />

Maternal education: NR<br />

Increased<br />

Concomitant therapies: Household income: NR<br />

NR<br />

Diagnostic approach:<br />

appetite:<br />

G1: 7 (30)<br />

N at enrollment:<br />

G1: 20<br />

In-study confirmation<br />

Diagnostic tool/method:<br />

G2: 6 (30)<br />

G1/G2: P = NS<br />

G2: 20<br />

N at follow-up:<br />

G1: 20<br />

G2: 20<br />

Semistructured interview<br />

with a score of ≥ 6 on the<br />

DSM-IV diagnosis criteria<br />

and clinical evaluation<br />

Dry mouth:<br />

G1: 4 (20)<br />

G2: 3 (15)<br />

G1/G2: P = NS<br />

Diagnostic category, n<br />

Fatigue:<br />

(%):<br />

G1: 5 (25)<br />

<strong>Autism</strong>: 40 (100)<br />

G2: 3 (15)<br />

Other characteristics, n:<br />

G1/G2: P = NS<br />

Extrapyramidal symptoms:<br />

Loss of appetite:<br />

G1: 6<br />

G1: 1 (5)<br />

G2: 8<br />

G2: 1 (5)<br />

G1/G2: P = 0.74<br />

G1/G2: P = NS<br />

Modifiers:<br />

NR<br />

Author:<br />

Inclusion criteria: Communication/ Communication/<br />

Allam et al., 2008 Intervention:<br />

• Age 4-7 years language:<br />

language:<br />

Country: Language therapy 2 times • Diagnosed with autism Language evaluation Language<br />

Egypt<br />

per week with or without according to DSM-IV- score, mean ± SD: evaluation score,<br />

Practice scalp acupuncture 2 times T criteria<br />

Attention:<br />

mean ± SD:<br />

setting:<br />

per week <strong>for</strong> 9 months • Diagnosed with autism G1: 1.4 ± 0.9 Attention:<br />

Academic (cycle of 20 minutes twice according to interview G2: 1.5 ± 0.8 G1: 2.8 ± 0.8<br />

Intervention weekly <strong>for</strong> 2 months with parents using Receptive semantics: G2: 3.1 ± 0.8<br />

setting:<br />

followed by 2 weeks rest) ADI-R<br />

G1: 5.2 ± 3.6 G1/BL: P = 0.021<br />

Acupuncture clinic Groups:<br />

• CARS score ≥ 30 G2: 5.0 ± 2.7 G2/BL: P = 0.001<br />

Enrollment G1: language therapy Exclusion criteria: Expressive semantics: G1/G2: P = 0.008<br />

period:<br />

G2: language therapy and • See inclusion criteria G1: 0.9 ± 0.6 Receptive<br />

9 months (dates acupuncture<br />

Age, years ± SD: G2: 0.7 ± 0.5 semantics:<br />

NR)<br />

Provider:<br />

G1: 5.5 ± 1.22<br />

Receptive syntax: G1: 7.0 ± 3.8<br />

Funding: • Same language G2: 5.5 ± 1.22<br />

G1: NR*<br />

G2: 9.4 ± 3.1<br />

C-115

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!